Improving Linkage to and Retention in Care in Newly Diagnosed HIV-Positive Patients Using Smartphones in South Africa: Randomized Controlled Trial

• Published in: JMIR mHealth and uHealth 2019-04, Vol.7 (4), p.e12652-e12652
• Main Authors: Venter, Willem Daniel Francois, Fischer, Alex, Lalla-Edward, Samanta Tresha, Coleman, Jesse, Lau Chan, Vincent, Shubber, Zara, Phatsoane, Mothepane, Gorgens, Marelize, Stewart-Isherwood, Lynsey, Carmona, Sergio, Fraser-Hurt, Nicole
• Format: Article
• Language: English
• Subjects: Acquired immune deficiency syndrome; Adolescent; Adult; AIDS; Female; HIV; HIV Infections - psychology; HIV Infections - therapy; Human immunodeficiency virus; Humans; Intervention; Male; Mobile Applications - standards; Mobile Applications - statistics & numerical data; Original Paper; Retention in Care - standards; Retention in Care - statistics & numerical data; Smartphone - instrumentation; Smartphone - statistics & numerical data; Smartphones; South Africa; Text messaging; Treatment Adherence and Compliance - psychology; Treatment Adherence and Compliance - statistics & numerical data; Zimbabwe
• ISSN: 2291-5222; 2291-5222
• DOI: 10.2196/12652

South Africa provides free antiretroviral therapy for almost 5 million people living with HIV, but only 71% of the eligible people are on treatment, representing a shortfall in the care cascade, especially among men and youth. Many developing countries have expanded access to smartphones; success in health apps raises the possibility of improving this cascade. SmartLink is a health app for Android smartphones providing HIV-related laboratory results, information, support, and appointment reminders to engage and link patients to care. This study aimed to evaluate the ability of SmartLink to improve linkage to care for HIV-positive smartphone owners. This study was a multisite randomized controlled trial in Johannesburg. The intervention arm received the app (along with referral to a treatment site) and the control arm received the standard of care (referral alone). Linkage to care was confirmed by an HIV-related blood test reported on the National Health Laboratory Service database between 2 weeks and 8 months after initiation. A total of 345 participants were recruited into the study; 64.9% (224/345) of the participants were female and 44.1% (152/345) were aged less than 30 years. In addition, 46.7% (161/345) were employed full time, 95.9% (331/345) had at least secondary school education, and 35.9% (124/345) were from Zimbabwe. Linkage to care between 2 weeks and 8 months was 48.6% (88/181) in the intervention arm versus 45.1% (74/164) in the control (P=.52) and increased to 64.1% (116/181) and 61.0% (100/164) (P=.55), respectively, after the initial 8-month period. Moreover, youth aged 18 to 30-years showed a statistically significant 20% increase in linkage to care for the intervention group. Youth aged less than 30 years have been historically difficult to reach with traditional interventions, and the SmartLink app provides a proof of concept that this population reacts to mobile health interventions that engage patients in HIV care. ClinicalTrials.gov NCT02756949; https://clinicaltrials.gov/ct2/show/NCT02756949 (Archived by WebCite at http://www.webcitation.org/6z1GTJCNW).